Search
for

    Glossary Naltrexone

    medication that blocks opioid receptors to reduce addiction cravings

    Naltrexone is a medication primarily used to manage alcohol and opioid dependence by blocking the euphoric and sedative effects of these substances. It is available under brand names such as Vivitrol and Revia, and works by binding to opioid receptors in the brain, thereby reducing cravings and the risk of relapse.

    Sort by

    Research 30 of 200

    1. The Opiate Antagonist, Naltrexone, in the Treatment of Trichotillomania Journal of Clinical Psychopharmacology · 2013 · 69 citations
    2. Novel Treatment Using Low-Dose Naltrexone for Lichen Planopilaris. PubMed · 2017 · 39 citations
    3. Trichotillomania Successfully Treated With Risperidone and Naltrexone: A Geriatric Case Report Journal of the American Medical Directors Association · 2014 · 13 citations
    4. Low-dose naltrexone: a novel adjunctive treatment in symptomatic alopecias? Dermatology Online Journal · 2019 · 4 citations
    5. Oral Low-Dose Naltrexone in the Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris: An Uncontrolled Open-Label Prospective Study Curēus · 2023 · 2 citations
    6. Biopharmaceutical Performance of DiluCap: A Line of Functional Excipients Enhancing Dissolution Profiles of Minoxidil, Finasteride, Melatonin, and Naltrexone. PubMed · 2025
    7. 41495 Efficacy of Oral Naltrexone in the Treatment of Scarring Alopecia Journal of the American Academy of Dermatology · 2023
    8. Literature Review: Naltrexone: New Use for an Old Drug Hair transplant forum international · 2018
    9. Attenuation of disease process following treatment with low-dose naltrexone in patients with frontal fibrosing alopecia and lichen planopilaris: A retrospective study Journal of the American Academy of Dermatology · 2024 · 3 citations
    10. Reversible Hair Loss in Lichen Planopilaris: Regrowth With Low-Dose Naltrexone and Platelet-Rich Plasma Journal of Drugs in Dermatology · 2022 · 1 citations
    11. Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment American Journal of Clinical Dermatology · 2019 · 61 citations
    12. Divergent neuroactive steroid responses to stress and ethanol in rat and mouse strains: relevance for human studies Psychopharmacology · 2014 · 34 citations
    13. Trichotillomania and Trichophagia: Modern Diagnostic and Therapeutic Methods Dermatology and Therapy · 2018 · 30 citations
    14. Recent advances in the treatment of trichotillomania (hair‐pulling disorder) Dermatologic Therapy · 2020 · 24 citations
    15. Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons Archives of Medical Science · 2022 · 20 citations
    16. Under-diagnosed psychiatric syndrome. I: Trichotillomania. PubMed · 1999 · 19 citations
    17. Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features 2022 · 13 citations
    18. Reply Journal of The American Academy of Dermatology · 1997 · 2 citations
    19. Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto Open Repository of the University of Porto (University of Porto) · 2025
    20. Actualización en el tratamiento de la tricotilomanía Actas Dermo-Sifiliográficas · 2024
    21. P087 The British Hair and Nail Society present a review of our national grand round of challenging hair disorders and the benefits to the wider British Association of Dermatologists membership British Journal of Dermatology · 2024
    22. British Hair and Nail SocietyOral presentationsBH01 (P087) The British Hair and Nail Society present a review of our national grand round of challenging hair disorders and the benefits to the wider British Association of Dermatologists membership British Journal of Dermatology · 2024
    23. Actualización en el tratamiento de la tricotilomanía 2024
    24. Hair-Pulling Disorder Oxford University Press eBooks · 2021
    25. Risk of Alopecia Areata with Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss medRxiv (Cold Spring Harbor Laboratory) · 2025
    26. Emerging Unconventional Therapies for Alopecia Areata Journal of Investigative Dermatology Symposium Proceedings · 2017 · 14 citations
    27. A narrative review of therapies for scalp dermatomyositis Dermatologic Therapy · 2021 · 7 citations
    28. ADVANCES IN THE TREATMENT OF ALCOHOL, OPIOID, AND CANNABIS ADDICTION Wiadomości Lekarskie · 2024
    29. A Review of the Characteristics of Clinical Trials and Potential Medications for Alcohol Dependence: Data Analysis from ClinicalTrials.gov Medicina · 2023 · 3 citations
    30. Intérêt des cheveux dans le diagnostic, la prise en charge et le suivi des sujets dépendants Annales de Toxicologie Analytique · 2017